InhaleRx Limited (IRX.AX)
AUD 0.02
(0.0%)
AUD 0.02
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.96 Million | -1.84 Million | -1.16 Million | -1.08 Million | -1.86 Million | -2.06 Million |
| Net Income | -1.44 Million | -1.92 Million | -1.11 Million | -1.2 Million | -2.38 Million | -1.67 Million |
| Depreciation & Amortization | - | 9707.00 | 1814.00 | - | 61.14 Thousand | 81.48 Thousand |
| Deferred income taxes | - | 37.25 Thousand | - | - | -240.29 Thousand | -26.59 Thousand |
| Stock-based compensation | 57.51 Thousand | 32.24 Thousand | - | - | 32.22 Thousand | - |
| Change in working capital | -590.81 Thousand | 49.72 Thousand | -43.55 Thousand | 126.69 Thousand | -77.75 Thousand | -278.26 Thousand |
| Other non-cash items | 697.37 Thousand | -48.18 Thousand | -8837.00 | -7186.00 | 746.23 Thousand | 265.56 Thousand |
| Investing Cash Flow | - | -175.00 | -25.09 Thousand | -4302.00 | -36.34 Thousand | -75.21 Thousand |
| Investments in PPE | - | -175.00 | -25.09 Thousand | -4302.00 | -36.34 Thousand | -10.81 Thousand |
| Acquisitions | - | - | - | - | - | -72.91 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -175.00 | -13.57 Thousand | -4302.00 | - | 8520.00 |
| Financing Cash Flow | 544.29 Thousand | 1.17 Million | 2.25 Million | 2.37 Million | 6598.00 | - |
| Debt repayment | -545.83 Thousand | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -1538.00 | -23.61 Thousand | -13.76 Thousand | - | - | - |
| Common Stock Issuance | -1538.00 | 1.2 Million | 2.27 Million | 2.4 Million | - | - |
| Other Financing Activities | 544.29 Thousand | 1.17 Million | 2.25 Million | -36.53 Thousand | - | - |
| Accounts receivables | -770.67 Thousand | -12.54 Thousand | 55.26 Thousand | 92.53 Thousand | 58.75 Thousand | 77.1 Thousand |
| Accounts payables | 145.52 Thousand | 80.85 Thousand | -55.9 Thousand | 39.71 Thousand | -144.52 Thousand | -345.07 Thousand |
| Inventory | - | 20.6 Thousand | -20.6 Thousand | - | - | - |
| Other working capital | 34.33 Thousand | -39.19 Thousand | -22.31 Thousand | -5549.00 | 8020.00 | -10.3 Thousand |
| Cash at beginning of period | 2.13 Million | 2.8 Million | 1.71 Million | 424.92 Thousand | 2.31 Million | 4.51 Million |
| Cash at end of period | 715.81 Thousand | 2.13 Million | 2.8 Million | 1.71 Million | 424.95 Thousand | 2.31 Million |
| Capital Expenditure | - | -175.00 | -25.09 Thousand | -4302.00 | -36.34 Thousand | -10.81 Thousand |
| Effect of forex changes on cash | - | 1.00 | -243.00 | -22.6 Thousand | 6374.00 | - |
| Net cash flow / Change in cash | -1.41 Million | -670.09 Thousand | 1.08 Million | 1.29 Million | -1.88 Million | -2.2 Million |
| Free Cash Flow | -1.96 Million | -1.84 Million | -1.18 Million | -1.09 Million | -1.9 Million | -2.07 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -368.78 Thousand | -368.78 Thousand | -19.23 Thousand | -1.44 Million | -9618.00 | -1.42 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 28.76 Thousand | 57.51 Thousand | 28.76 Thousand | - |
| Change in working capital | - | - | -368.16 Thousand | -590.81 Thousand | -368.16 Thousand | - |
| Other non-cash items | 350.58 Thousand | 350.58 Thousand | -336.76 Thousand | 697.37 Thousand | 171.02 Thousand | -181.82 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -173.39 Thousand | -173.39 Thousand | 545.83 Thousand | 544.29 Thousand | 272.91 Thousand | -1538.00 |
| Debt repayment | -346.78 Thousand | - | -545.83 Thousand | -545.83 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -1538.00 | - | - |
| Common Stock Issuance | - | - | - | -1538.00 | - | -1538.00 |
| Other Financing Activities | -173.39 Thousand | -173.39 Thousand | 272.91 Thousand | 544.29 Thousand | 272.91 Thousand | -769.00 |
| Accounts receivables | - | - | -385.33 Thousand | -770.67 Thousand | -385.33 Thousand | - |
| Accounts payables | - | - | - | 145.52 Thousand | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | 17.17 Thousand | 34.33 Thousand | 17.17 Thousand | - |
| Cash at beginning of period | 715.81 Thousand | - | 525.99 Thousand | 2.13 Million | - | 2.13 Million |
| Cash at end of period | 332.63 Thousand | -191.59 Thousand | 715.81 Thousand | 715.81 Thousand | 94.91 Thousand | 525.99 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -383.18 Thousand | -191.59 Thousand | 189.82 Thousand | -1.41 Million | 94.91 Thousand | -1.6 Million |
| Free Cash Flow | -18.2 Thousand | -18.2 Thousand | -356 Thousand | -1.96 Million | -178 Thousand | -1.6 Million |
QLIS
688569
AMNP
ABDA
688051
ASTR